These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22537445)

  • 1. Is hepatitis virus resistance to antiviral drugs a threat?
    Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1369-72. PubMed ID: 22537445
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Viruses and antiviral drug resistance].
    Hovi T; Järvinen A; Pyhälä R; Ristola M; Salminen M
    Duodecim; 2002; 118(9):911-8. PubMed ID: 12238169
    [No Abstract]   [Full Text] [Related]  

  • 4. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
    Cheruvu S; Marks K; Talal AH
    Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis viruses and human immunodeficiency virus co-infection: pathogenesis and treatment.
    Vallet-Pichard A; Pol S
    J Hepatol; 2004 Jul; 41(1):156-66. PubMed ID: 15246224
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
    J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to overcome antiviral-resistant hepatitis B virus?
    Song BC
    Intervirology; 2010; 53(1):29-38. PubMed ID: 20068338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Marcellin P; Lada O
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S5-8. PubMed ID: 17075487
    [No Abstract]   [Full Text] [Related]  

  • 9. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
    Locarnini S; Warner N
    Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic interventions for HIV infection and chronic viral hepatitis.
    Cooper CL
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S69-72. PubMed ID: 16265617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
    Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM;
    Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Bourlière M
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
    [No Abstract]   [Full Text] [Related]  

  • 13. Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infection.
    Dervisevic S; Pillay D
    J HIV Ther; 2003 Nov; 8(4):89-95. PubMed ID: 14671506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist?
    Zoulim F
    Hepatology; 2006 Dec; 44(6):1404-7. PubMed ID: 17133478
    [No Abstract]   [Full Text] [Related]  

  • 15. Special considerations and treatment of patients with HBV-HIV coinfection.
    Dieterich DT
    Antivir Ther; 2007; 12 Suppl 3():H43-51. PubMed ID: 18284182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summary of BHIVA guidelines for HIV and hepatitis B or C co-infection.
    Brook MG
    J HIV Ther; 2003 Nov; 8(4):85-8. PubMed ID: 14671505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic hepatitis B and the implications of viral resistance to therapy.
    Mauss S; Wedemeyer H
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):191-9. PubMed ID: 18380601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection.
    Zoulim F
    Antiviral Res; 2004 Oct; 64(1):1-15. PubMed ID: 15451174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of chronic hepatitis B: new goals and new treatments.
    Mauss S
    Minerva Med; 2009 Dec; 100(6):447-58. PubMed ID: 20010480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Definitions of resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Zoulim F
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S9-11. PubMed ID: 17075488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.